Four endocrinologists to join Board of Directors
Endocrine Society members elected Stephen R. Hammes, M.D., Ph.D., to serve as the organization’s President for the 2023-2024 term.
Hammes is the Louis S. Wolk Distinguished Professor of Medicine, Chief of the Division of Endocrinology, Diabetes and Metabolism, and Vice-Chair for Research and Academic Affairs in the Department of Medicine at the University of Rochester in Rochester, N.Y. He will serve as President-Elect for a year beginning in June 2022 before becoming President in June 2023.
Hammes’ laboratory studies steroid signaling, and his clinical focus is on gonadal and adrenal diseases, as well as transgender health. He has served on several Endocrine Society committees and is currently Deputy Editor of the Journal of the Endocrine Society and the Annual Meeting Steering Committee Chair for ENDO 2022.
The Society’s Nominating Committee also selected four members to join its Board of Directors beginning in June 2022. The new Board members are:
The new Board members will begin serving their three-year terms following ENDO 2022. The Society’s annual meeting will take place in Atlanta, Ga., from June 11-14, 2022.
Dr. Ahima is the Director of the Division of Endocrinology, Diabetes and Metabolism, Bloomberg Distinguished Professor of Diabetes in the Schools of Medicine, Public Health and Nursing, and the leader of the Johns Hopkins Diabetes Initiative at Johns Hopkins University in Baltimore, Md. He is a member of the Laureate Awards Committee and an Associate Editor of Endocrine Reviews.
Dr. Gore is Professor of Pharmacology & Toxicology and Vacek Chair in Pharmacology at the University of Texas at Austin in Austin, Texas. Her laboratory focuses on neuroendocrine control of reproduction and connections among hormones, brain sexual differentiation and behavior. She’s a member of the Endocrine Society’s Endocrine-disrupting Chemicals (EDC) Advisory Group and co-chairs the Society’s EDCs Writing Group.
Dr. Lam is Chair Professor in Medicine, Rosie TT Young Professor in Endocrinology & Metabolism, Clinical Director of the State Key Laboratory of Pharmaceutical Biotechnology, and Academic Lead of the Clinical Trial Center, at the University of Hong Kong in Hong Kong. She serves on the Society’s Publication Core Committee and is an Associate Editor of The Journal of Clinical Endocrinology & Metabolism.
Dr. Onumah is the Medical Director of the Luminis Health Anne Arundel Medical Center’s Diabetes and Endocrinology Program in Bowie, Md. She was previously a faculty member at Medstar Washington Hospital Center Endocrine Training Program, where she served as an Assistant Professor at Georgetown University Hospital. She was also a member of the Society’s Committee on Diversity and Inclusion and is currently on the Laureate Awards Committee.
About Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.
Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 [email protected]
Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
